What Does Wall Street See for Medidata Solutions's Q2?
Medidata Solutions (NAS: MDSO) is expected to report Q2 earnings on July 25. Here's what Wall Street wants to see:
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Medidata Solutions's revenues will expand 24.7% and EPS will grow 26.1%.
The average estimate for revenue is $66.7 million. On the bottom line, the average EPS estimate is $0.29.
Last quarter, Medidata Solutions tallied revenue of $63.3 million. GAAP reported sales were 26% higher than the prior-year quarter's $50.4 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at $0.35. GAAP EPS of $0.22 for Q1 were 47% higher than the prior-year quarter's $0.15 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 72.9%, 190 basis points better than the prior-year quarter. Operating margin was 11.3%, 100 basis points worse than the prior-year quarter. Net margin was 9.0%, 150 basis points better than the prior-year quarter.
The full year's average estimate for revenue is $274.3 million. The average EPS estimate is $1.30.
The stock has a two-star rating (out of five) at Motley Fool CAPS, with 57 members out of 66 rating the stock outperform, and nine members rating it underperform. Among 18 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 16 give Medidata Solutions a green thumbs-up, and two give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Medidata Solutions is outperform, with an average price target of $59.67.
Is Medidata Solutions the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.
- Add Medidata Solutions to My Watchlist.
The article What Does Wall Street See for Medidata Solutions's Q2? originally appeared on Fool.com.Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor ofMotley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.